160 related articles for article (PubMed ID: 29881317)
1. Development and validation of a revised instrument to measure burden of long-term medicines use: the Living with Medicines Questionnaire version 3.
Katusiime B; Corlett SA; Krska J
Patient Relat Outcome Meas; 2018; 9():155-168. PubMed ID: 29881317
[TBL] [Abstract][Full Text] [Related]
2. Validation of an instrument to measure patients' experiences of medicine use: the Living with Medicines Questionnaire.
Krska J; Katusiime B; Corlett SA
Patient Prefer Adherence; 2017; 11():671-679. PubMed ID: 28405159
[TBL] [Abstract][Full Text] [Related]
3. Cross-Cultural Adaptation and Reliability Testing of Chinese Version of the Living with Medicines Questionnaire in Elderly Patients with Chronic Diseases.
Wang Y; Krska J; Lin B; Mei Y; Katusiime B; Guo Y; Zhang Z
Patient Prefer Adherence; 2020; 14():2477-2487. PubMed ID: 33363363
[TBL] [Abstract][Full Text] [Related]
4. Patient experiences of the burden of using medicines for long-term conditions and factors affecting burden: A cross-sectional survey.
Krska J; Katusiime B; Corlett SA
Health Soc Care Community; 2018 Nov; 26(6):946-959. PubMed ID: 30058749
[TBL] [Abstract][Full Text] [Related]
5. Exploring Medicines Burden Among Adults in New Zealand: A Cross-Sectional Survey.
Tordoff JM; Brenkley C; Krska J; Smith A
Patient Prefer Adherence; 2019; 13():2171-2184. PubMed ID: 31908424
[TBL] [Abstract][Full Text] [Related]
6. Medication-related burden from the perspective of the elderly.
Alqallaf SM; Matar L; Ghuloom K; Alabbad K; Alshaikh F; Alhaddad M
Med Pharm Rep; 2022 Jul; 95(3):320-331. PubMed ID: 36060508
[TBL] [Abstract][Full Text] [Related]
7. Psychometric validation of the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) in Chinese patients with adolescent idiopathic scoliosis.
Cheung PWH; Wong CKH; Samartzis D; Luk KDK; Lam CLK; Cheung KMC; Cheung JPY
Scoliosis Spinal Disord; 2016; 11():19. PubMed ID: 27525314
[TBL] [Abstract][Full Text] [Related]
8. Translation, Cross-Cultural Adaptation, and Psychometric Testing of Yoruba Version of the EQ-5D Questionnaire in Patients With Musculoskeletal Disorders.
Fatoye F; Akinfala AE; Gebrye T; Fatoye C; Ojelade TF; Oyewole OO; Mbada CE
Front Public Health; 2022; 10():902680. PubMed ID: 35832283
[TBL] [Abstract][Full Text] [Related]
9. Exploring polypharmacy burden among elderly patients with chronic diseases in Chinese community: a cross-sectional study.
Wang Y; Li X; Jia D; Lin B; Fu B; Qi B; Zhang Z
BMC Geriatr; 2021 May; 21(1):308. PubMed ID: 33985446
[TBL] [Abstract][Full Text] [Related]
10. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
Wong CKH; Lang BHH; Yu HMS; Lam CLK
Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
[TBL] [Abstract][Full Text] [Related]
11. Assessing medication-related burden of community-dwelling individuals with chronic conditions in a small island state.
Sacco K; West LMB; Grech LM; Krska J; Cordina M
Chronic Illn; 2023 Oct; ():17423953231205918. PubMed ID: 37801519
[TBL] [Abstract][Full Text] [Related]
12. Psychometric validation of anti-clot treatment scale and treatment satisfaction questionnaire for medication version II in Japanese patients with atrial fibrillation.
Watanabe-Fujinuma E; Banderas BF; Koretsune Y; Kumagai K; Uchiyama S; Yamashita T; Yasaka M; Akiyama S; Briere JB; Dickie G; Cano SJ
J Med Econ; 2019 Aug; 22(8):798-805. PubMed ID: 30995146
[No Abstract] [Full Text] [Related]
13. Reliability and validity of the EQ-5D-3L for Kashin-Beck disease in China.
Fang H; Farooq U; Wang D; Yu F; Younus MI; Guo X
Springerplus; 2016; 5(1):1924. PubMed ID: 27917330
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of an instrument for measuring the burden of medicine on functioning and well-being: the Medication-Related Burden Quality of Life (MRB-QoL) tool.
Mohammed MA; Moles RJ; Hilmer SN; Kouladjian O'Donnel L; Chen TF
BMJ Open; 2018 Jan; 8(1):e018880. PubMed ID: 29330175
[TBL] [Abstract][Full Text] [Related]
15. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications.
Bharmal M; Payne K; Atkinson MJ; Desrosiers MP; Morisky DE; Gemmen E
Health Qual Life Outcomes; 2009 Apr; 7():36. PubMed ID: 19397800
[TBL] [Abstract][Full Text] [Related]
16. Translation and psychometric validation of a Danish version of the medication-related quality of life scale.
Lech LVJ; Jónsdóttir ED; Niclasen J; Treldal C; Graabæk T; Almarsdóttir AB
Int J Clin Pharm; 2020 Apr; 42(2):667-676. PubMed ID: 32026349
[TBL] [Abstract][Full Text] [Related]
17. A pilot study on the validity and psychometric properties of the electronic EQ-5D-5L in routine clinical practice.
Lam CLK; Tse ETY; Wong CKH; Lam JSM; Chen SS; Bedford LE; Cheung JPY; Or CK; Kind P
Health Qual Life Outcomes; 2021 Dec; 19(1):266. PubMed ID: 34922564
[TBL] [Abstract][Full Text] [Related]
18. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
Cheung PWH; Wong CKH; Cheung JPY
Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
[TBL] [Abstract][Full Text] [Related]
19. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
20. Validity and reliability of EQ-5D-5L among patients with axial spondyloarthritis in Singapore.
Seng JJB; Kwan YH; Fong W; Phang JK; Lui NL; Thumboo J; Leung YY
Eur J Rheumatol; 2020 Apr; 7(2):71-78. PubMed ID: 32644927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
